APA (7th ed.) Citation

Ochenduszko, S., Landete, L., Martinez, D. C., Feria, A. G., Francés, C., Torregrosa, M. D., & Maiques, I. M. (2024). Cytokine release syndrome and immune effector cell‑associated neurotoxicity syndrome in a melanoma patient treated with adjuvant pembrolizumab. Experimental & Therapeutic Medicine, 28(5), N.PAG. https://doi.org/10.3892/etm.2024.12712

Chicago Style (17th ed.) Citation

Ochenduszko, Sebastian, Lamberto Landete, David Collado Martinez, Ana García Feria, Carla Francés, María Dolores Torregrosa, and Inmaculada Maestu Maiques. "Cytokine Release Syndrome and Immune Effector Cell‑associated Neurotoxicity Syndrome in a Melanoma Patient Treated with Adjuvant Pembrolizumab." Experimental & Therapeutic Medicine 28, no. 5 (2024): N.PAG. https://doi.org/10.3892/etm.2024.12712.

MLA (9th ed.) Citation

Ochenduszko, Sebastian, et al. "Cytokine Release Syndrome and Immune Effector Cell‑associated Neurotoxicity Syndrome in a Melanoma Patient Treated with Adjuvant Pembrolizumab." Experimental & Therapeutic Medicine, vol. 28, no. 5, 2024, p. N.PAG, https://doi.org/10.3892/etm.2024.12712.